非洲心血管疾病患者的代谢综合征：系统回顾与荟萃分析

IF 2.3 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Clinical Epidemiology and Global Health Pub Date : 2024-10-10 DOI:10.1016/j.cegh.2024.101817

{"title":"非洲心血管疾病患者的代谢综合征：系统回顾与荟萃分析","authors":"","doi":"10.1016/j.cegh.2024.101817","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Metabolic syndrome, a frequent precursor to many cardiovascular illnesses, is prevalent in Africa. Currently, research on the prevalence of metabolic syndrome among cardiovascular disease patients is limited to diabetic, HIV/AIDS, and psychiatric populations. As a result, there is a lack of systematic evidence on the prevalence of metabolic syndrome among individuals with cardiovascular disease in African countries, and there is no realistic picture of the continent’s prevalence of metabolic syndrome among individuals with cardiovascular disease. This systematic review aimed to estimate the prevalence of metabolic syndrome among individuals with cardiovascular disease.</div></div><div><h3>Methods</h3><div>This systematic review and meta-analysis is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement guidelines. Systematic electronic searches using databases such as African Journal Online, Google Scholar, PubMed, and the Wiley Online Library were performed from March 15 to April 20, 2024, to retrieve all relevant primary articles reporting the prevalence of metabolic syndrome among patients with cardiovascular disease in Africa. The extracted data were entered into Microsoft Excel and analyzed using STATA version 11 (STATA Corp., LLC) to estimate the pooled prevalence. Heterogeneity was tested using the <em>Q</em> statistic, and the <em>I</em><sup>2</sup> test was used to identify possible inter-study variations.</div></div><div><h3>Results</h3><div>The initial search identified 1804 articles, which were cataloged in citation management software (EndNote X 7). The current meta-analysis showed that the overall prevalence of metabolic syndrome among patients with cardiovascular disease was 38.96% (95% CI: 30.51–47.42, I<sup>2</sup> = 73.2%) according to the NCEP-ATP III criteria. The analysis revealed moderate heterogeneity between the included articles. As a result, a random effect model, specifically the Der-Simonian and Laird (D+L) random model, was used to estimate the pooled prevalence of metabolic syndrome among patients with cardiovascular disease.</div></div><div><h3>Conclusion</h3><div>The prevalence of metabolic syndrome is increasing at an alarming rate and is high in Africa. Therefore, policymakers, clinicians, and concerned stakeholders should develop effective strategies for the control, prevention, and management of metabolic syndrome.</div></div>","PeriodicalId":46404,"journal":{"name":"Clinical Epidemiology and Global Health","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Metabolic syndrome among patients with cardiovascular disease in Africa: a systematic review and meta-analysis\",\"authors\":\"\",\"doi\":\"10.1016/j.cegh.2024.101817\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Metabolic syndrome, a frequent precursor to many cardiovascular illnesses, is prevalent in Africa. Currently, research on the prevalence of metabolic syndrome among cardiovascular disease patients is limited to diabetic, HIV/AIDS, and psychiatric populations. As a result, there is a lack of systematic evidence on the prevalence of metabolic syndrome among individuals with cardiovascular disease in African countries, and there is no realistic picture of the continent’s prevalence of metabolic syndrome among individuals with cardiovascular disease. This systematic review aimed to estimate the prevalence of metabolic syndrome among individuals with cardiovascular disease.</div></div><div><h3>Methods</h3><div>This systematic review and meta-analysis is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement guidelines. Systematic electronic searches using databases such as African Journal Online, Google Scholar, PubMed, and the Wiley Online Library were performed from March 15 to April 20, 2024, to retrieve all relevant primary articles reporting the prevalence of metabolic syndrome among patients with cardiovascular disease in Africa. The extracted data were entered into Microsoft Excel and analyzed using STATA version 11 (STATA Corp., LLC) to estimate the pooled prevalence. Heterogeneity was tested using the <em>Q</em> statistic, and the <em>I</em><sup>2</sup> test was used to identify possible inter-study variations.</div></div><div><h3>Results</h3><div>The initial search identified 1804 articles, which were cataloged in citation management software (EndNote X 7). The current meta-analysis showed that the overall prevalence of metabolic syndrome among patients with cardiovascular disease was 38.96% (95% CI: 30.51–47.42, I<sup>2</sup> = 73.2%) according to the NCEP-ATP III criteria. The analysis revealed moderate heterogeneity between the included articles. As a result, a random effect model, specifically the Der-Simonian and Laird (D+L) random model, was used to estimate the pooled prevalence of metabolic syndrome among patients with cardiovascular disease.</div></div><div><h3>Conclusion</h3><div>The prevalence of metabolic syndrome is increasing at an alarming rate and is high in Africa. Therefore, policymakers, clinicians, and concerned stakeholders should develop effective strategies for the control, prevention, and management of metabolic syndrome.</div></div>\",\"PeriodicalId\":46404,\"journal\":{\"name\":\"Clinical Epidemiology and Global Health\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Epidemiology and Global Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213398424003142\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Epidemiology and Global Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213398424003142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

摘要

导言代谢综合征是许多心血管疾病的常见前兆，在非洲非常普遍。目前，有关代谢综合征在心血管疾病患者中发病率的研究仅限于糖尿病患者、艾滋病毒/艾滋病患者和精神病患者。因此，关于代谢综合征在非洲国家心血管疾病患者中的患病率缺乏系统的证据，非洲大陆心血管疾病患者的代谢综合征患病率也没有真实的描述。本系统综述旨在估算代谢综合征在心血管疾病患者中的患病率。方法本系统综述和荟萃分析根据系统综述和荟萃分析首选报告项目声明指南进行报告。从 2024 年 3 月 15 日至 4 月 20 日，我们使用非洲期刊在线、谷歌学术、PubMed 和 Wiley 在线图书馆等数据库进行了系统的电子检索，以检索所有报告非洲心血管疾病患者代谢综合征患病率的相关主要文章。提取的数据被输入 Microsoft Excel，并使用 STATA 11 版本（STATA Corp.使用 Q 统计量检验异质性，并使用 I2 检验确定研究间可能存在的差异。目前的荟萃分析表明，根据 NCEP-ATP III 标准，心血管疾病患者代谢综合征的总患病率为 38.96%（95% CI：30.51-47.42，I2 = 73.2%）。分析显示，纳入的文章之间存在中度异质性。因此，我们采用了随机效应模型，特别是 Der-Simonian 和 Laird（D+L）随机模型，来估算心血管疾病患者中代谢综合征的总体患病率。因此，决策者、临床医生和相关利益方应制定有效的代谢综合征控制、预防和管理策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Metabolic syndrome among patients with cardiovascular disease in Africa: a systematic review and meta-analysis

Introduction

Metabolic syndrome, a frequent precursor to many cardiovascular illnesses, is prevalent in Africa. Currently, research on the prevalence of metabolic syndrome among cardiovascular disease patients is limited to diabetic, HIV/AIDS, and psychiatric populations. As a result, there is a lack of systematic evidence on the prevalence of metabolic syndrome among individuals with cardiovascular disease in African countries, and there is no realistic picture of the continent’s prevalence of metabolic syndrome among individuals with cardiovascular disease. This systematic review aimed to estimate the prevalence of metabolic syndrome among individuals with cardiovascular disease.

Methods

This systematic review and meta-analysis is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement guidelines. Systematic electronic searches using databases such as African Journal Online, Google Scholar, PubMed, and the Wiley Online Library were performed from March 15 to April 20, 2024, to retrieve all relevant primary articles reporting the prevalence of metabolic syndrome among patients with cardiovascular disease in Africa. The extracted data were entered into Microsoft Excel and analyzed using STATA version 11 (STATA Corp., LLC) to estimate the pooled prevalence. Heterogeneity was tested using the Q statistic, and the I² test was used to identify possible inter-study variations.

Results

The initial search identified 1804 articles, which were cataloged in citation management software (EndNote X 7). The current meta-analysis showed that the overall prevalence of metabolic syndrome among patients with cardiovascular disease was 38.96% (95% CI: 30.51–47.42, I² = 73.2%) according to the NCEP-ATP III criteria. The analysis revealed moderate heterogeneity between the included articles. As a result, a random effect model, specifically the Der-Simonian and Laird (D+L) random model, was used to estimate the pooled prevalence of metabolic syndrome among patients with cardiovascular disease.

Conclusion

The prevalence of metabolic syndrome is increasing at an alarming rate and is high in Africa. Therefore, policymakers, clinicians, and concerned stakeholders should develop effective strategies for the control, prevention, and management of metabolic syndrome.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Epidemiology and Global Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

4.60

自引率

7.70%

发文量

218

审稿时长

66 days

期刊介绍： Clinical Epidemiology and Global Health (CEGH) is a multidisciplinary journal and it is published four times (March, June, September, December) a year. The mandate of CEGH is to promote articles on clinical epidemiology with focus on developing countries in the context of global health. We also accept articles from other countries. It publishes original research work across all disciplines of medicine and allied sciences, related to clinical epidemiology and global health. The journal publishes Original articles, Review articles, Evidence Summaries, Letters to the Editor. All articles published in CEGH are peer-reviewed and published online for immediate access and citation.